These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 31560828)

  • 21. Options for the Treatment of Mucinous Ovarian Carcinoma.
    Craig O; Salazar C; Gorringe KL
    Curr Treat Options Oncol; 2021 Nov; 22(12):114. PubMed ID: 34773517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular approaches to personalizing management of ovarian cancer.
    Bast RC
    Ann Oncol; 2011 Dec; 22 Suppl 8(Suppl 8):viii5-viii15. PubMed ID: 22180401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
    Martin-Lluesma S; Graciotti M; Grimm AJ; Boudousquié C; Chiang CL; Kandalaft LE
    Curr Opin Biotechnol; 2020 Oct; 65():190-196. PubMed ID: 32334152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.
    Marchetti C; De Felice F; Romito A; Iacobelli V; Sassu CM; Corrado G; Ricci C; Scambia G; Fagotti A
    Semin Cancer Biol; 2021 Dec; 77():144-166. PubMed ID: 34464704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Tumor Heterogeneity in High-Grade Serous Ovarian Cancer: Mass Cytometry to Understand the Complex Tumor Biology.
    Pasquini L; Riccioni R; Petrucci E
    Methods Mol Biol; 2022; 2535():105-118. PubMed ID: 35867226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.
    Holloway RW; Mehta RS; Finkler NJ; Li KT; McLaren CE; Parker RJ; Fruehauf JP
    Gynecol Oncol; 2002 Oct; 87(1):8-16. PubMed ID: 12468336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements.
    Akter S; Rahman MA; Hasan MN; Akhter H; Noor P; Islam R; Shin Y; Rahman MDH; Gazi MS; Huda MN; Nam NM; Chung J; Han S; Kim B; Kang I; Ha J; Choe W; Choi TG; Kim SS
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line and subsequent therapy for ovarian carcinoma.
    Peethambaram PP; Long HJ
    Curr Oncol Rep; 2002 Mar; 4(2):159-64. PubMed ID: 11822988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.
    Capriglione S; Luvero D; Plotti F; Terranova C; Montera R; Scaletta G; Schirò T; Rossini G; Benedetti Panici P; Angioli R
    Med Oncol; 2017 Aug; 34(9):164. PubMed ID: 28825178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.
    Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial ovarian cancer: a review of current management.
    Guppy AE; Nathan PD; Rustin GJ
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):399-411. PubMed ID: 16149282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1.
    Chardin L; Leary A
    Front Oncol; 2021; 11():795547. PubMed ID: 34966689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting ovarian cancer using extracellular vesicles: progress and possibilities.
    Carollo E; Paris B; Samuel P; Pantazi P; Bartelli TF; Dias-Neto E; Brooks SA; Pink RC; Carter DRF
    Biochem Soc Trans; 2019 Feb; 47(1):295-304. PubMed ID: 30700499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy.
    Gibbs DD; Gore ME
    Drugs; 2001; 61(8):1103-20. PubMed ID: 11465872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
    Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
    J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.